About April Schleck
Form D filings for Escalante Bioscience in 2024 list April Schleck as executive officer and director.
April Schleck first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name April Schleck in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people April Schleck works with at each company, as listed on that company's latest Form D.
Escalante Bioscience, Inc. · Form D, May 17, 2024